The overlap syndromes of autoimmune hepatitis (Q38037392)

27 August 2017

The overlap syndromes of autoimmune hepatitis (English)

1 reference

27 August 2017

Albert J Czaja

1

1 reference

27 August 2017

24 August 2012

1 reference

Digestive Diseases and Sciences

27 August 2017

1 reference

27 August 2017

58

1 reference

27 August 2017

2

1 reference

27 August 2017

326-343

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-012-2367-1

27 August 2017

0 references

cites work

Active chronic hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Abnormal bile duct epithelium in chronic aggressive hepatitis and cirrhosis. A review of morphology and clinical, biochemical, and immunologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Cholestasis in active chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Chronic active hepatitis: the challenge for a new nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Simplified criteria for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Advances in the diagnosis, pathogenesis, and management of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

The variant forms of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis and its variant syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Performance parameters of the diagnostic scoring systems for autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Serologic markers do not predict histologic severity or response to treatment in patients with autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Comparison of the applicability of two prognostic scoring systems in patients with fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Variant forms of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Diagnosis and management of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Diagnosis and management of primary sclerosing cholangitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Variant syndromes of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis with incidental histologic features of bile duct injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune cholangitis syndrome with a bias towards primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Primary biliary cirrhosis and autoimmune cholangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Overcoming a "probable" diagnosis in antimitochondrial antibody negative primary biliary cirrhosis: study of 100 sera and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis in children: what is different from adult AIH?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Unique features of primary sclerosing cholangitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Sclerosing cholangitis: pediatric perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Identification and characterization of IgG4-associated autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Clinical significance of immunoglobulin G4-associated autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Frequency, behavior, and prognostic implications of antimitochondrial antibodies in type 1 autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Plasma cells and the chronic nonsuppurative destructive cholangitis of primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Characteristics and long-term prognosis of the autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis and overlap syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Overlap of primary biliary cirrhosis and primary sclerosing cholangitis - a rare coincidence or a new syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Establishment of standardised SLA/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Overlap syndromes among autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Histology of autoimmune hepatitis and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Systematic review: management options for primary sclerosing cholangitis and its variant forms - IgG4-associated cholangitis and overlap with autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

The role of histologic evaluation in the diagnosis and management of autoimmune hepatitis and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Identification of p53 as a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune overlapping syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Frequency of antibody to hepatitis C virus in asymptomatic HBsAg-negative chronic active hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Hepatitis C virus infection as a determinant of behavior in type 1 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Transitions between variant forms of primary biliary cirrhosis during long-term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Development of autoimmune hepatitis in primary biliary cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Understanding the pathogenesis of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis. Part A: pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis in childhood: a 20-year experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Prognosis in primary biliary cirrhosis: model for decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Current and future treatments of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis: focusing on treatments other than steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Advances in the current treatment of autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Autoimmune hepatitis: the dilemma of rare diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

'Acute' autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-012-2367-1

Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status

21 January 2018

1 reference

12 December 2020

Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis

1 reference

12 December 2020

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

12 December 2020

Performance parameters of the conventional serological markers for autoimmune hepatitis

1 reference

12 December 2020

Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial

1 reference

12 December 2020

Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.

1 reference

12 December 2020

Evaluating distinctive features for early diagnosis of primary sclerosing cholangitis overlap syndrome in adults with autoimmune hepatitis

1 reference

12 December 2020

Validation of scoring system for diagnosis of autoimmune hepatitis

1 reference

12 December 2020

Overlap of autoimmune hepatitis and primary biliary cirrhosis: an evaluation of a modified scoring system

1 reference

12 December 2020

Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I.

1 reference

12 December 2020

Ludwig Symposium on biliary disorders. Autoimmune cholangitis: a unique entity?

1 reference

12 December 2020

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

12 December 2020

Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.

1 reference

12 December 2020

Autoimmune cholangitis within the spectrum of autoimmune liver disease

1 reference

12 December 2020

Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival

1 reference

12 December 2020

Primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome: A rationale for corticosteroids use based on a nation-wide retrospective study in Japan

1 reference

12 December 2020

Small-duct primary sclerosing cholangitis: a long-term follow-up study

1 reference

12 December 2020

Chronic liver disease in young people. Clinical features and course in thirty-three patients

1 reference

12 December 2020

PSC, AIH and overlap syndrome in inflammatory bowel disease

1 reference

12 December 2020

Autoimmune Hepatitis–PBC Overlap Syndrome: A Simplified Scoring System May Assist in the Diagnosis

1 reference

12 December 2020

Meeting report: International Autoimmune Hepatitis Group

1 reference

12 December 2020

Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome

1 reference

12 December 2020

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

12 December 2020

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

1 reference

12 December 2020

THE COURSE AND TREATMENT OF LUPOID HEPATITIS

1 reference

12 December 2020

Variant forms of cholestatic diseases involving small bile ducts in adults

1 reference

12 December 2020

Primary sclerosing cholangitis: refinement and validation of survival models

1 reference

12 December 2020

A novel histological lesion in glucocorticoid-responsive chronic hepatitis

1 reference

12 December 2020

Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases

1 reference

12 December 2020

Does HLA-DR7 differentiate the overlap syndrome of auto-immune hepatitis-primary biliary cirrhosis (AIH-PBC) from those with auto-immune hepatitis type 1?

1 reference

12 December 2020

Mycophenolate mofetil for the treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid

1 reference

12 December 2020

Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome.

1 reference

12 December 2020

Frequency and nature of the variant syndromes of autoimmune liver disease

1 reference

12 December 2020

Antimitochondrial antibody-negative primary biliary cirrhosis

1 reference

12 December 2020

Clinical implications of antimitochondrial antibodies in type 1 autoimmune hepatitis: a longitudinal study

1 reference

12 December 2020

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A

1 reference

12 December 2020

Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a foray across diagnostic boundaries

1 reference

12 December 2020

Autoimmune hepatitis with initial presentation as acute hepatic failure in young children

1 reference

12 December 2020

Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study

1 reference

12 December 2020

Co-existence of primary biliary cirrhosis and primary sclerosing cholangitis: a rare overlap syndrome put in perspective

1 reference

12 December 2020

Autoimmune chronic active hepatitis masquerading as acute hepatitis

1 reference

12 December 2020

Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution

1 reference

12 December 2020

Comparability of probable and definite autoimmune hepatitis by international diagnostic scoring criteria

1 reference

12 December 2020

Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases

1 reference

12 December 2020

Shared autoimmunity: a concept for which the time has come

1 reference

12 December 2020

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis

1 reference

12 December 2020

Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis

1 reference

12 December 2020

The usefulness of IgG and IgM immunostaining of periportal inflammatory cells (plasma cells and lymphocytes) for the distinction of autoimmune hepatitis and primary biliary cirrhosis and their staining pattern in autoimmune hepatitis-primary biliary

1 reference

12 December 2020

Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus

1 reference

12 December 2020

The validity and importance of subtypes in autoimmune hepatitis: a point of view

1 reference

12 December 2020

Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus

1 reference

12 December 2020

A scoring system for primary biliary cirrhosis and its application for variant forms of autoimmune liver disease

1 reference

12 December 2020

Pathogenesis of autoimmune hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis

1 reference

12 December 2020

Presence of antimitochondrial autoantibodies in patients with autoimmune hepatitis

1 reference

12 December 2020

Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease

1 reference

12 December 2020

The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study

1 reference

12 December 2020

Shared genetic risk factors in autoimmune liver disease

1 reference

12 December 2020

Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis

1 reference

12 December 2020

The nature and prognostic implications of autoimmune hepatitis with an acute presentation

1 reference

12 December 2020

Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.

1 reference

12 December 2020

Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy

1 reference

12 December 2020

High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis

1 reference

12 December 2020

Clinicopathological study of primary biliary cirrhosis negative for antimitochondrial antibodies

1 reference

12 December 2020

HLA-DR allele frequencies in Mexican mestizos with autoimmune liver diseases including overlap syndromes

1 reference

12 December 2020

Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology

1 reference

12 December 2020

Immunoglobin G4-hepatopathy: association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis

1 reference

12 December 2020

Adrenal cortical metabolism in chronic liver disease

1 reference

12 December 2020

Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis

1 reference

12 December 2020

10.1007/S10620-012-2367-1

Identifiers

DOI

1 reference

PubMed ID

22918690

Dimensions Publication ID

27 August 2017

1029536241

0 references

Fatcat ID

release_tngajv6mnvg5rm2wlmhebigjjy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tngajv6mnvg5rm2wlmhebigjjy

24 November 2022

mapped directly with Wikidata item

PubMed ID

22918690

1 reference

PubMed ID

22918690